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Abstract
Objective: The aim of this study was to evaluate the results of thyroid fine 
needle aspiration cytology (FNAC) and identify reasons for discrepancies 
between the cytological and histological diagnoses in our institution.
Materials and Methods: We evaluated the results of 1064 FNACs obtained 
from 737 patients, of which 98 underwent subsequent thyroid surgery.
Results: Histological analyses revealed that benign diagnoses based on 
FNAC were correct in 76 of the 80 benign cases (95%), with four cases 
being underdiagnosed (false negatives). Two of the four cases were due 
to incidental findings of papillary microcarcinomas. The third case was 
due to a cytologic sampling error and the fourth was due to cytologic 
underdiagnosis. Furthermore, malignant diagnoses based on FNAC were 
correct in 17 of the 18 malignant cases (94%), with one case being over-
diagnosed (false positive) due to over-interpretation of Hürthle cells as 
carcinomatous cells. The accuracy, positive predictive value, and negative 
predictive value were 94.9%, 94.4%, and 95.0%, respectively.
Conclusion: Overall, FNAC is a sensitive and specific method for the pre-
operative screening of thyroid nodules. However, due to limitations under 
some specific circumstances, such as papillary microcarcinoma, bizarre 
Hürthle cells, follicular neoplasm and technical difficulty during the aspi-
ration, the management of thyroid nodules must not only depend on the 
results of FNAC but should also be correlated with clinical findings before 
surgical intervention. [Tzu Chi Med J 2008;20(4):296–303]
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1. Introduction
The prevalence of thyroid nodules has been estimated 
to be as high as 25% or more in iodine-deficient 
regions, whereas only 4–7% of the population is esti-
mated to have thyroid abnormalities in non-iodine-
deficient areas [1]. In Taiwan, the incidence of adult 
goiter is 19.4% in men, 33.6% in women, and 25% 
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in the total population [2]. Furthermore, it is estimated 
that only 5–10% of non-toxic thyroid nodules are ma-
lignant [3,4]. Thus, the main goal for clinicians is to 
distinguish between benign and malignant nodules 
in order to decrease the number of unnecessary 
thyroidectomies.
A number of researchers have demonstrated that 
physical examination, thyroid scintigraphy, thermog-
raphy, X-ray techniques, thyroid hormone suppression, 
and ultrasonography are not reliable with respect to 
identifying neoplastic thyroid nodules. In contrast, 
thyroid fine needle aspiration cytology (FNAC) has 
been shown to be a simple, safe, reliable and cost-
effective technique for detecting malignant nodules 
and has been purported to be the diagnostic method 
of choice in the initial approach to patients with thy-
roid nodules [5–7]. Since the introduction of FNAC, 
the total number of thyroid surgeries has markedly 
decreased [8]. However, in spite of its well recognized 
value, there are drawbacks to thyroid FNAC, including 
a high number of inadequate aspirates, the inability 
to reliably distinguish follicular adenoma from follic-
ular carcinoma, and the possibility of false-negative 
and false-positive diagnoses [7,9–12].
The aim of this study was to evaluate the accuracy 
of thyroid FNAC and identify reasons for discrepancies 
between the cytological and histological diagnoses 
in our institution.
2. Materials and methods
From August 2003 through May 2007, a total of 1064 
consecutive thyroid FNACs from 737 patients (111 
male, 626 female) were conducted at the Buddhist 
Dalin Tzu Chi General Hospital in Chiayi, Taiwan, and 
included for evaluation in this study. In 190 cases, 
more than one (2–8 times) aspirate was performed 
due to various reasons, including inadequate speci-
men, routine follow-up, multiple nodules, and recon-
firmation of cellular atypia or suggested malignancy. 
The mean age of the patients was 51.8 years (range, 
13–92 years). Of the 737 patients, 98 (13.3%) sub-
sequently underwent surgery.
Fine needle aspirations of the thyroid nodules were 
performed by one of four clinicians using 23-gauge 
needles attached to 5 or 10 mL disposable syringes 
using either the free-hand procedure or sonographic 
guidance according to each patient’s clinical findings. 
For each aspiration, two to six alcohol-fixed and air-
dried smears were prepared and stained using the 
methods of Papanicolaou and/or Liu as the clinicians 
preferred. A smear was considered satisfactory if it 
contained at least five to six groups of 10–15 well-
preserved, well-visualized follicular cells [13]. Cystic 
lesions with numerous hemosiderin-laden macro-
phages and few or no follicular cells were regarded 
as satisfactory with a qualifier indicating that the in-
terpretation was limited due to the paucity or lack of 
follicular cells [14].
Cytological diagnoses following FNAC were classi-
fied according to four groups as follows: (1) negative 
for malignancy; (2) cellular atypia; (3) suggestive of ma-
lignancy; and (4) malignant. Cytological specimens 
without evidence of cellular atypia or malignancy were 
classified as negative for malignancy. Aspirates dis-
playing atypical cells with equivocal nature were in-
cluded in the cellular atypia group. Smears exhibiting 
unequivocal or somewhat equivocal cytological pic-
tures of malignancy were categorized in the malignant 
and suggestive of malignancy groups, respectively.
When comparing the cytological diagnosis with the 
definitive histological diagnosis of the 98 subjects 
who underwent surgery, the categories negative for 
malignancy and cellular atypia were collectively 
grouped as benign. Similarly, the suggestive of malig-
nancy and malignant categories were collectively 
grouped as malignant. The cytological and histologi-
cal diagnoses were evaluated for concordance (same 
diagnosis) and discordance (different diagnoses). His-
tological sections and cytological smears of the dis-
crepant cases were reviewed to ascertain the reasons 
for the discordance.
Finally, the following parameters were calculated 
according to the standard criteria: sensitivity, specifi-
city, positive predictive value (PPV), negative predic-
tive value (NPV), accuracy, false-positive rate (FPR), 
and false-negative rate (FNR) [15].
3. Results
Of the 1064 FNACs, 999 (93.9%) aspirates were clas-
sified as negative for malignancy, 40 (3.8%) as cel-
lular atypia, 19 (1.8%) as suggestive of malignancy, 
and six (0.5%) as malignant (Table 1 and Fig. 1). Diag-
noses in the negative for malignancy group included 
benign follicular cells in 426 aspirates, hemorrhagic 
cyst in 248 aspirates, nodular goiter in 213 aspirates, 
follicular lesions in 29 aspirates, thyroiditis in nine 
aspirates, as well as dissatisfaction due to inadequate 
cellularity or poorly fixed smears in 74 aspirates. 
Ninety-eight patients (13.3%) had undergone surgical 
intervention. The distribution of the 98 histopatho-
logical results and their correlation with the four cy-
tological categories are shown in Tables 1 and 2. Of 
the 21 malignant cases identified by histopathology 
that underwent surgery, four were not diagnosed using 
FNAC. The cytohistologic correlation of the four false-
negative cases and the reasons for the discrepancies 
are summarized in Table 3. Two of the four false-
negative cases were due to incidental findings of 
papillary microcarcinomas. The other two cases were 
due to cytological sampling error and interpretation 
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error, respectively. Furthermore, of the 77 histologi-
cally benign cases, one was misdiagnosed as malig-
nant. This false-positive case was due to interpretation 
of Hashimoto’s thyroiditis as carcinoma.
The group of cellular atypia included 40 cases in 
which nine (22.5%) subjects underwent thyroidec-
tomy. Surgical diagnoses included three nodular goi-
ters with hemorrhagic cystic degeneration, two Hürthle 
cell adenomas, two Hashimoto’s thyroiditis, one fol-
licular adenoma and one subacute thyroiditis. None 
in the nine surgical cases showed malignancy. Of the 
Table 1 — Correlation between four cytologic categories and histopathologic results
Category of cytologic diagnosis
 Number of cases Number of cases undergoing surgery
 based on FNAC and diagnosis based on FNAC
Negative for malignancy 999   71
  Nodular goiter with cystic degeneration 31 
  Nodular goiter 26 
  Follicular adenoma 5 
  Papillary microcarcinoma 2 
  Hürthle cell adenoma 2 
  Papillary carcinoma 2 
  Subacute thyroiditis 1 
  Psammomatous nodular hyperplasia 1 
  Autoimmune thyroiditis 1 
Cellular atypia 40   9
  Nodular goiter with cystic degeneration 3 
  Hürthle cell adenoma 2 
  Hashimoto’s thyroiditis 2 
  Follicular adenoma 1 
  Subacute thyroiditis 1 
Suggestive of malignancy 19   14
  Papillary carcinoma 10 
  Follicular carcinoma 1 
  Angiosarcoma 1 
  Papillary microcarcinoma 1 
  Hashimoto’s thyroiditis 1 
Malignant 6   4
  Papillary carcinoma 3 
  Hürthle cell carcinoma 1 
Total 1064   98
Table 2 — Comparison of cytologic results to histopatho-
logic results
 Histologic results
FNAC results
 Malignant Benign Total
Malignant* 17 1 18
Benign† 4 76 80
Total 21 77 98
*Malignant + suggestive of malignancy groups in FNACs; †negative for 
malignancy + cellular atypia groups in FNACs.
Fig. 1 — Distribution of cytologic diagnoses in 1064 FNACs.
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19 cases in the suggestive of malignancy group, 14 
underwent surgery. Histological evaluation revealed 
12 carcinomas and one angiosarcoma. Furthermore, 
one case in this group presented with Hashimoto’s 
thyroiditis but no malignancy. Finally, of the six cases 
in the malignant group, four underwent surgery with 
histological evaluation revealing carcinomas in all 
four cases. The surgical rate of the cytological malig-
nant group was 72.0%.
A total of 40 follicular lesions including 29 cases 
of them categorized as negative for malignancy and 
11 cases as cellular atypia were diagnosed using 
FNAC with 12 (30.0%) of these subjects receiving 
surgical intervention. Histological diagnoses included 
three follicular adenomas, three Hürthle cell ade-
nomas, two nodular goiters, two Hashimoto’s thy-
roiditis, one follicular carcinoma, and one follicular 
variant of papillary carcinoma. The cytologic accu-
racy in diagnosing follicular neoplasm was roughly 
58.3% (7/12).
Based on the above results, the following parame-
ters were calculated: (1) sensitivity, 81% (17/21); (2) 
specificity, 98.7% (76/77); (3) FPR, 1.3% (1/77); (4) 
FNR, 19.0% (4/21); (5) PPV, 94.4% (17/18); (6) NPV, 
95.0% (76/80); and (7) accuracy, 94.9% (93/98). In 
addition, the dissatisfaction rate was 7.0% (74/1064). 
Five of the 74 unsatisfactory cases underwent thy-
roidectomy. In these five cases, the histological re-
sults showed two nodular goiters with hemorrhagic 
cystic degeneration, one nodular goiter, and two nod-
ular goiters with papillary microcarcinomas. These 
calculated parameters based on our results are com-
pared in Table 4 with the data from six other studies 
published after 2000 [11,16–20].
4. Discussion
FNAC is an accurate preoperative screening method 
for the evaluation of thyroid nodules and helps to 
distinguish malignant nodules from benign nodules 
for the purpose of distinguishing patients in need of 
surgical intervention [21]. Overall, the current study 
confirms the predictive value of FNAC as a diagnostic 
tool. However, false-positive and false-negative cases 
remain. Although the 1996 guidelines for FNAC of 
thyroid nodules established that the aim of the pro-
cedure is to achieve a FNR and FPR less than 2% and 
3%, respectively [14], these ideal goals have been 
difficult to achieve as evidenced by higher than ideal 
rates in several recent reports (Table 4). In our current 
study, the FPR was 1.3%, similar to that in other re-
ported studies with FPR between 0.5% and 26.3%.
The one false positive based on FNAC in our cur-
rent report was due to erroneous interpretation of 
the Hürthle cells in Hashimoto’s thyroiditis as carci-
nomatous cells. Notably, these Hürthle cells exhibited 
enlarged hyperchromatic nuclei, prominent nucleoli, 
occasional nuclear grooves and an increased nuclear 
to cytoplasm ratio (Fig. 2). Hürthle cells (also referred 
to as Ashkenazy cells) are the result of metaplastic 
changes in the follicular cells, which are large, poly-
gonal square shaped cells with abundant granular and 
polychromatic cytoplasm and hyperchromatic nuclei 
with prominent “cherry-pink” macronucleoli [22]. 
Using Liu’s stain, the finely pink cytoplasmic granules 
are more prominent than in the Papanicolaou stain. 
Owing to occasional nuclear grooves and intranuclear 
pseudoinclusions in the Hürthle cells, they are easily 
misidentified as malignant cells. This error was also 
Table 3 — Causes of discrepancies in the four false-negative cases based on histopathology
Case Cytological diagnosis Histological diagnosis Discrepant causes
1 Nodular goiter Papillary microcarcinoma (0.2 cm), nodular goiter Incidental finding
2 Negative for malignant cell (some microfollicles) Papillary carcinoma (1.2 cm) Sampling error
3 Microfollicular lesion Papillary carcinoma (2.5 cm), follicular variant,  Cytologic underdiagnosis
   Hürthle cell adenoma, and nodular goiter
4 Inadequate smear (bloody smear only) Papillary microcarcinoma (0.7 cm), nodular goiter Incidental finding
Table 4 — Comparison of the results of this study with other reported series published after 2000
Authors Year
 Sensitivity Specificity FPR FNR PPV NPV Accuracy Dissatisfaction
  (%) (%) (%) (%) (%) (%) (%) (%)
Bakhos et al [16] 2000 93.0 96.0 8.0 4.0 – – 88.0 7.0
Amrikachi et al [17] 2001 93.0 96.0 11.7 7.0 – – – 29.0
Morgan et al [18] 2003 55.0 73.7 26.3 45.8 70.0 67.4 67.2 14.0
Ko et al [11] 2003 78.4 98.2 1.8 21.5 99.0 66.3 84.4 –
Jogai et al [19] 2005 88.4 99.1 0.5 3.6 – – 78.1 2.6
Cai et al [20] 2006 83.3 98.0 5.7 – 71.4 98.4 97.0 –
This study 2008 81.0 98.7 1.3 19.0 94.4 95.0 94.9 7.0
FPR = false-positive rate; FNR = false-negative rate; PPV = positive predictive value; NPV = negative predictive value; – = unknown data.
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reported by Ylagan et al in 2004 [23]. The presence of 
nuclear grooves among Hürthle cells in some cases 
of chronic lymphocytic thyroiditis and nodular hyper-
plasia was the most frequent cause of false-positive 
cases in their report [23]. Indeed, in our study, for five 
of the nine surgical cases in the cellular atypia group, 
cellular atypia of the related FNACs were due to 
Hürthle cells. Cytologically, it is difficult to assess the 
nature of Hürthle cells, especially when few cells are 
present and the fixation of the aspirate is less than 
optimal. Thus, when the nature of the Hürthle cells is 
uncertain, differential diagnoses should include nor-
mal variations in Hürthle cell morphology in thyroid 
follicles, nodular goiter with Hürthle cells, Hashimoto’s 
thyroiditis, Hürthle cell adenoma/carcinoma, and 
Hürthle cell variant of papillary carcinoma. In addition, 
it should be known that the presence of a nuclear 
groove is not a specific feature of papillary carcinoma. 
A nuclear groove might also be present in Hashimoto’s 
thyroiditis, follicular adenoma/carcinoma, and Hürthle 
cell neoplasm [23]. A case demonstrating some clus-
ters of enlarged hyperchromatic nuclei of Hürthle cells 
with nuclear grooves was cytologically misdiagnosed 
as suggestive of papillary carcinoma in our study 
(Fig. 3). Finally, the surgical thyroid tissue presented 
a Hürthle cell adenoma with a large hemorrhagic 
cyst, which showed a ringed patch of angiosarcoma 
within an inner cystic wall.
The FNR in our study was 19.0%, which is similar 
to recent reports that showed FNRs between 3.6% 
and 45.8%. The causes of the four false-negative 
cases are summarized in Table 3. In two of the cases, 
histological evaluation revealed incidental findings 
of papillary microcarcinoma in addition to the main 
nodular goiters, which were the feature of interest 
when the FNACs were performed. In the other two 
cases, the false negatives were due to cytological 
sampling errors and cytological misdiagnosis of a 
follicular variant of papillary carcinoma as a micro-
follicular lesion. The prevalence of papillary micro-
carcinomas has been reported to be between 6.2% 
and 11.3% [24–26], with the exception of the highest 
reported prevalence rate of 35.6% reported in Finland 
[27]. Yamamoto et al noted that the incidence of 
papillary microcarcinomas is high in cases with ade-
nomatous goiters [26]. This phenomenon was also 
present in our current study as well as in other stud-
ies [19,23]. However, it is extremely difficult to diag-
nose this small neoplasm (< 1 cm in diameter) using 
FNAC, especially when it is adjacent to a relatively 
large nodular goiter, which is usually the main target 
lesion in FNAC. Indeed, papillary microcarcinomas 
are generally incidental findings after surgical inter-
vention of a clinically or ultrasonographically found 
nodule. Some authors do not consider these inciden-
tal microcarcinomas as true false-negative cases [28]. 
However, Yang et al pointed out that some of these 
microcarcinomas were clinically meaningful lesions 
because they might be multifocal and have lymph 
node metastases [29].
The follicular variant of papillary carcinoma is a 
pitfall in thyroid FNAC. Cytologically, it presents with 
hypercellularity with a prominent follicular pattern 
but no obvious papillae. Syncytial follicular cells, nu-
clear grooves, intranuclear pseudoinclusion and chew-
ing gum colloid have been reported to be occasionally 
present in variable proportions [30]. However, none 
of these cytological pictures are specific, and may 
present in adenomatous goiters, follicular adenomas 
and follicular carcinomas at varying frequencies [19]. 
Leung et al revealed that the true nature of the histo-
logical variants of the papillary carcinoma cannot be 
predicted from the appearances of the FNAC [31]. 
Ylagan et al reported a cytologic follicular variant of 
papillary carcinoma, commenting that although the 
presence of a nuclear groove is nonspecific, it may be 
the only finding for this diagnosis [23]. In our present 
case, we histologically identified a 2.5-cm follicular 
variant of papillary carcinoma combined with a 1.1-cm 
Hürthle cell adenoma and a 1-cm nodular goiter. 
Cytologically, this papillary carcinoma demonstrated 
some microfollicles and Hürthle cells. Focally, follic-
ular cells demonstrated moderately enlarged, hyper-
chromatic nuclei, scanty intranuclear pseudoinclusions 
and subtle nuclear grooves. We believe that aspects 
of these cytological features concealed a follicular 
variant of papillary carcinoma, rendering it difficult 
to make an accurate diagnosis cytologically.
One of the drawbacks of FNAC is its high unsatis-
factory rate due to poor fixation and/or inadequate 
cellularity for interpretation. An experienced staff 
Fig. 2 — A cluster of Hürthle cells exhibiting enlarged 
hyperchromatic and pleomorphic nuclei, prominent 
nucleoli, and occasional nuclear grooves. Some lym-
phocytes (arrows) are also noted in the background. This 
Hashimoto’s thyroiditis was misdiagnosed as suspicious 
for papillary carcinoma cytologically. (Papanicolaou stain, 
1000´.)
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can lower the poor fixation rate. The acceptable in-
adequate rate is less than 15% [14]. However, an in-
adequate smear might be a result of thyroid nodular 
character or inadequate sampling. Sclerotic, calcified 
or large cystic nodules are difficult to aspirate [10]. A 
sonographically guided aspirate could improve spec-
imen acquisition [20,32]. The unsatisfactory rate in 
the current study was 7% and consistent with that 
reported in other recent studies, which range be-
tween 2.6% and 29.0% (Table 4). However, in five of 
the unsatisfactory cases that underwent surgery in 
the current study, two exhibited nodular goiters with 
papillary microcarcinomas. Although these malignan-
cies were incidental findings, this highlights the need 
to re-aspirate all unsatisfactory samples before mak-
ing definitive diagnoses [18,23,33]. Indeed, it is im-
portant to educate clinicians that an unsatisfactory 
smear does not equal a negative smear.
The other major drawback of FNAC is the lack of re-
liability with respect to distinguishing follicular ade-
noma from follicular carcinoma [7,34,35]. The reason 
for this is that the diagnosis of each entity is based 
on histological criteria, i.e., vascular and/or capsular 
invasion. FNAC cannot provide this information. The 
intraoperative frozen section is also handicapped in 
these cases because the histological diagnosis of fol-
licular carcinoma often requires multiple sections 
with good preservation of morphology, which are not 
available in the frozen state. In addition, owing to 
the various overlapping cytological features, the dif-
ferential diagnoses of cytological follicular patterns 
should include adenomatous nodule, follicular ade-
noma/carcinoma, and follicular variant of papillary 
carcinoma [19]. The results of our study are similar to 
previously reported results. Twelve of 40 subjects with 
cytologically identified follicular lesions underwent 
thyroidectomy, revealing three follicular adenomas, 
one follicular carcinoma, three Hürthle cell adenomas, 
two nodular goiters with hemorrhagic cystic degen-
eration, and one follicular variant of papillary carci-
noma. In addition, two cases of Hashimoto’s thyroiditis 
also showed follicular lesions cytologically with subtle 
Fig. 3 — (A) A cluster of Hürthle cells exhibiting enlarged overlapping and irregular-sized nuclei with obvious nucleoli 
and nuclear grooves (arrow). These were cytologically diagnosed as suspicious for papillary carcinoma (Papanicolaou 
stain, 1000´). (B) However, the finally histologic evaluation revealed an angiosarcoma arising in a Hürthle cell ade-
noma. This picture showed the Hürthle cell adenoma (right upper part) with a central angiosarcoma (left lower part, 
hematoxylin & eosin, 200´). Immunohistochemical staining for angiosarcomatous cells shows positive staining for: (C) 
vimentin (400´); and (D) factor-VIII (400´).
A
C D
B
Vimentin Factor-VIII
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Hürthle cells and lymphocytic background, which were 
misinterpreted as naked follicular nuclei. Although 
follicular neoplasm is the handicap of FNAC, clinical 
information may complement this finding in some 
situations. A cytological follicular lesion associated 
with age > 40 years, size > 3 cm, and male gender might 
increase the risk of malignancy and should be more 
aggressively treated [12]. However, in our study, only 
one 4.7-cm follicular carcinoma was histologically 
diagnosed in a 70-year-old female.
In this study, the accuracy, PPV, and NPV were 
94.9%, 94.4%, and 95.0%, respectively. The data 
were similar to those in recent reports (Table 4), dem-
onstrating that thyroid FNAC is a reliable screening 
test and also a valuable method of distinguishing neo-
plastic from non-neoplastic nodules preoperatively. 
However, owing to some limitations of FNAC as dis-
cussed above, it is recommended that surgical indi-
cations must not depend solely on cytology. Indeed, 
the results of medical history, physical examination, 
laboratory tests, and ultrasonography should also be 
evaluated simultaneously.
In conclusion, thyroid FNAC is a sensitive and spe-
cific method for screening thyroid nodules. However, 
owing to stationary limitations, such as the inability 
to reliably distinguish follicular adenoma from fol-
licular carcinoma, difficulties in detecting papillary 
microcarcinomas, probability of over-interpreting 
Hürthle cells as carcinomatous cells and some tech-
nical difficulties and errors, the management of thy-
roid nodules must not depend only on FNAC. 
Correlating the results of FNACs with clinical findings 
is a must before surgical intervention is suggested in 
selected patients.
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